Table 1

Baseline characteristics of patients with Alzheimer's disease and their caregivers who participated in the Danish Alzheimer Intervention Study (DAISY)

Intervention (n=163)Control (n=167)
Patients’ characteristics
Sex
 Male76 (46.6)75 (44.9)
 Female87 (53.4)92 (55.1)
Mean (SD) age (years)76.5 (7.7)75.9 (6.6)
Household status
 Living alone54 (33.1)48 (28.7)
 Living with others109 (66.9)119 (71.3)
Home
 Rented66 (40.5)56 (33.5)
 Owned97 (59.5)111 (66.5)
Education
 None60 (36.8)57 (34.1)
 <3 years39 (23.9)49 (29.3)
 ≥3 years64 (39.3)61 (36.5)
Charlson comorbidity index
 No comorbidity64 (39.3)73 (43.7)
 1 comorbidity75 (46.0)65 (38.9)
 ≥2 comorbidities24 (14.7)29 (17.4)
Diagnosis
 Pure Alzheimer's disease112 (68.7)127 (76.1)
 Mixed Alzheimer's disease and vascular dementia44 (27.0)38 (22.8)
 Lewy body dementia7 (4.3)2 (1.2)
Caregiver's characteristics
 Sex
 Male54 (33.1)56 (33.5)
 Female109 (66.9)111 (66.5)
Mean (SD) age (years)65.5 (12.7)66.5 (12.7)
Relation
 Spouse104 (63.8)111 (66.5)
 Child or child in law45(27.6)41(24.5)
 Other14 (8.6)15 (9.0)
Living with patient
 Yes101/162 (62.4)112/166 (67.5)
 No61/162 (37.6)54/166 (32.5)
Home
 Rent45 (27.6)45 (26.9)
 Own118 (72.4)122 (73.1)
Education
 None41 (25.2)37/166 (22.3)
 <3 years46 (28.2)63/166 (37.9)
 ≥3 years76 (46.6)66 /166 (39.8)
Outcome measures at baseline
Primary patient outcomes
 Mean (SD) MMSE24.0 (2.5)24.1 (2.7)
 Mean (SD) Cornell Depression Scale5.2 (4.8)4.4 (4.0)
 Mean (SD) proxy-rated EQ-VAS62.1 (18.4) (n=162)64.7 (20.4)
Primary caregiver outcome
 Mean (SD) EQ-VAS79.3 (16.3) (n=162)81.4 (16.3)
 Mean (SD) GDS4.74 (5.2) (n=162)4.71 (5.0)
Secondary patient outcome
 Mean (SD) QoL-AD (proxy-rated)33.0 (6.1)34.7 (6.6)
 Mean (SD) NPI-Q3.9 (3.6)3.9 (3.7)
 Mean (SD) ADSC-ADL61.2 (11.4)61.8 (11.4)
  • Values are numbers (percentages) of participants unless stated otherwise.

  • ADSC-ADL, Alzheimer's Disease Cooperative Study Activities of Daily Living Scale; EQ-VAS, European Quality of Life Visual Analogue Scale; GDS, Geriatric Depression Scale; MMSE, Mini-Mental State Examination; NPI-Q, Neuropsychiatric Inventory Questionnaire; QoL-AD, Quality of Life Scale for Alzheimer's Disease.